Stay updated on PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Sign up to get notified when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.

Latest updates to the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page
- Check5 days agoChange DetectedFooter updates include removal of the HHS Vulnerability Disclosure and a new Revision: v3.3.3 in the footer replacing v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing v3.3.1; there are no changes to study details, eligibility criteria, outcomes, or contacts, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page now displays a revision tag Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check41 days agoChange DetectedNotice about government funding delays and operating status updates has been removed from the page.SummaryDifference0.5%

- Check55 days agoChange DetectedThe new screenshot shows a redesigned header and page layout; all study details such as eligibility criteria, endpoints, and enrollment appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check84 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference6%

Stay in the know with updates to PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PET/CT in HER2+ Tumors Before MT-5111 Clinical Trial page.